The U.S. Food and Drug Administration authorized the marketing of five JUUL e-cigarette products through the Premarket Tobacco Product Application (PMTA) pathway. The approved products include the JUUL device and Virginia Tobacco and Menthol JUULpods in both 3% and 5% nicotine concentrations. The decision followed a thorough scientific review of data submitted by JUUL Labs, including a two-year study showing a significant number of adult smokers switching completely from cigarettes to these JUUL products. The FDA concluded that the potential benefits to adult smokers outweigh the risks to non-users, including youth.

Despite the authorization, the FDA emphasized that these products are not "FDA approved" and do not represent a safe tobacco option. The agency will continue monitoring compliance with strict marketing restrictions to prevent youth exposure and will take enforcement action if requirements are violated. The FDA reiterated that tobacco products should only be used by adults 21 and older and warned that no tobacco product is safe for use by non-smokers or youth.

Consumer News Region
Consumer News Tags
USA; E-cigarette; Premarket Tobacco Product Application (PMTA); Tobacco